IBM commits $2 billion to America’s first pure-play quantum chip foundry
The investment marks a significant expansion in domestic semiconductor manufacturing, with IBM establishing a dedicated quantum fabrication hub as part of broader funding distributed across nine companies.
IBM has established a $2 billion investment under the US CHIPS Act to create America’s first pure-play quantum chip foundry in Anderson. The facility is designed to utilise 300mm superconducting silicon technology, marking a distinct shift in domestic semiconductor manufacturing capabilities. This announcement, reported by Futurum Group, positions the Anderson site as a dedicated hub for quantum chip fabrication, separate from general-purpose semiconductor operations.
The term “pure-play” indicates that the new facility will focus exclusively on quantum chip production. This specialisation distinguishes the Anderson foundry from traditional semiconductor plants that handle a broader range of chip types. By committing to 300mm superconducting silicon technology, IBM is targeting a specific technological pathway for quantum computing hardware, aiming to scale production capabilities for this emerging sector.
This $2 billion allocation is part of a broader CHIPS Act funding package distributed across nine companies. The CHIPS Act serves as a US legislative programme intended to bolster domestic semiconductor manufacturing and reduce reliance on foreign supply chains. While the total investment for the Anderson foundry is confirmed, the specific breakdown of how the $2 billion is distributed among the nine participating companies has not been detailed in the source material.
The announcement comes from a commentary piece by Futurum Group, an industry analysis firm. While the headline refers to IBM “spinning off” the foundry, the underlying text describes the establishment of the facility through investment. This distinction regarding corporate structure changes requires careful interpretation, as the source frames the event as a new creation rather than a corporate divestment.
Claims regarding the Anderson facility being the “first” of its kind in America should be viewed within the context of the available reporting. The source identifies it as the first pure-play quantum chip foundry, but independent verification of this status against global or domestic competitors is not provided in the current data. The timeline for the completion or operational launch of the Anderson facility is also not specified.
IBM’s involvement in this project aligns with its broader history in quantum computing research and development. The move to establish a dedicated fabrication plant suggests a strategic pivot from research towards scalable manufacturing. As part of the nine companies receiving CHIPS Act funding, IBM’s investment underscores the growing importance of quantum hardware in the national semiconductor strategy.
The focus on 300mm superconducting silicon technology highlights a specific technical approach to quantum chip production. This method differs from other quantum computing architectures, potentially offering distinct advantages in terms of scalability or coherence times. The establishment of a dedicated foundry for this technology indicates IBM’s confidence in this pathway for future quantum computing hardware.
